Clinical Trials Directory

Trials / Unknown

UnknownNCT05305469

Early Identification and Prognosis Prediction of Sepsis Through Multiomics

Status
Unknown
Phase
Study type
Observational
Enrollment
900 (estimated)
Sponsor
Yantai Yuhuangding Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

This study aims to integrate multi-omics data and clinical indicators to reveal pathogen-specific molecular patterns in patients with sepsis and establish prognostic prediction models through multiple machine learning algorithms.

Detailed description

This study aims to quantify the plasma metabolome, single nucleotide polymorphisms (SNPs) of exons and immunocytokines of septic patients with different pathogen infections and prognostic outcomes. Multi-omics data, cytokines, and clinical indicators will be integrated through multiple machine learning algorithms to reveal pathogen-specific molecular patterns and multi-dimensional prognostic prediction models.

Conditions

Timeline

Start date
2022-01-01
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2022-03-31
Last updated
2024-01-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05305469. Inclusion in this directory is not an endorsement.